Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
MacroGenics, Inc. - Common Stock
(NQ:
MGNX
)
1.580
+0.040 (+2.60%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 16, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about MacroGenics, Inc. - Common Stock
< Previous
1
2
...
5
6
7
8
9
10
11
12
Next >
MacroGenics to Participate in Upcoming Investor Conferences
April 24, 2023
From
MacroGenics, Inc.
Via
GlobeNewswire
Why Tupperware Brands Shares Are Trading Lower By Over 40%? Here Are Other Stocks Moving In Monday's Mid-Day Session
April 10, 2023
Gainers PLx Pharma Inc. (NASDAQ: PLXP) gained 128.2% to $0.2399 after dropping over 13% on Thursday.
Via
Benzinga
What 4 Analyst Ratings Have To Say About Macrogenics
March 21, 2023
Via
Benzinga
Why MacroGenics Stock Tumbled Today
March 17, 2023
The company had quite a comedown shortly after releasing its latest set of annual results.
Via
The Motley Fool
Macrogenics's Return On Capital Employed Insights
March 16, 2023
Via
Benzinga
MacroGenics (MGNX) Q4 2022 Earnings Call Transcript
March 15, 2023
MGNX earnings call for the period ending December 31, 2022.
Via
The Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
April 03, 2023
Via
Benzinga
Incyte Would Now Compete With Merck, Pfizer As Its Skin Cancer Treatment Scores FDA Accelerated Approval
March 23, 2023
Via
Benzinga
MacroGenics Earns $15 Million Milestone Following U.S. FDA Approval of ZYNYZ™ (retifanlimab-dlwr)
March 22, 2023
From
MacroGenics, Inc.
Via
GlobeNewswire
Why MacroGenics Stock Inched Higher on Monday
March 20, 2023
A pair of more-bullish analyst evaluations gave hope to investors.
Via
The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For March 17, 2023
March 17, 2023
Via
Benzinga
Why Shares of MacroGenics Climbed Thursday
March 16, 2023
The cancer-focused biotech delivered a strong earnings report.
Via
The Motley Fool
Signet Jewelers, Designer Brands, Academy Sports and Outdoors And Other Big Stocks Moving Higher On Thursday
March 16, 2023
U.S. stocks traded lower, with the Dow Jones dropping more than 250 points on Thursday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
Why Titan Machinery Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
March 16, 2023
Gainers Lipella Pharmaceuticals Inc. (NASDAQ: LIPO) shares jumped 40.2% to $2.5109 after the company announced the successful completion of a Phase 2A clinical trial evaluating the safety and efficacy...
Via
Benzinga
Illumina, Seagen And Other Big Stocks Moving Higher On Monday
March 13, 2023
U.S. stocks traded slightly lower, with the Nasdaq Composite dropping around 0.2% on Monday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
Earnings Scheduled For March 15, 2023
March 15, 2023
Companies Reporting Before The Bell • Sportradar Gr (NASDAQ:SRAD) is estimated to report quarterly earnings at $0.04 per share on revenue of $208.09 million.
Via
Benzinga
Why Shares of MacroGenics Jumped Thursday
March 09, 2023
The company made a sale worth as much as $200 million for the royalty rights for its type-1 diabetes therapy.
Via
The Motley Fool
12 Health Care Stocks Moving In Thursday's Intraday Session
March 09, 2023
Via
Benzinga
General Electric, Build-A-Bear Workshop, Asana And Other Big Stocks Moving Higher On Thursday
March 09, 2023
U.S. stocks traded higher, with the Dow Jones gaining around 50 points on Thursday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
March 09, 2023
Via
Benzinga
MacroGenics Announces Sale of TZIELD™ Royalty Interest for up to $200 Million
March 08, 2023
From
MacroGenics, Inc.
Via
GlobeNewswire
MacroGenics Announces Date of Fourth Quarter 2022 Financial Results Conference Call
March 07, 2023
From
MacroGenics, Inc.
Via
GlobeNewswire
MacroGenics to Participate in Upcoming Investor Conferences
March 02, 2023
From
MacroGenics, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Monday's Intraday Session
February 20, 2023
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
February 17, 2023
Via
Benzinga
AutoNation, HubSpot, AMC Networks And Other Big Stocks Moving Higher On Friday
February 17, 2023
U.S. stocks traded lower, with the Nasdaq Composite dropping over 100 points on Friday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
Around $11M Bet On Insight Enterprises? Check Out These 4 Stocks Insiders Are Buying
February 17, 2023
Although US stocks closed lower on Thursday, there were a few notable insider trades.
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
February 14, 2023
Via
Benzinga
MacroGenics Posts Interim Data From Lorigerlimab Study In Prostate Cancer Patients
February 14, 2023
Via
Benzinga
MacroGenics Announces Preliminary Clinical Results from Single Arm Study of Lorigerlimab in Patients with Metastatic Castration-Resistant Prostate Cancer to be Presented at ASCO Genitourinary Cancers Symposium
February 13, 2023
From
MacroGenics, Inc.
Via
GlobeNewswire
< Previous
1
2
...
5
6
7
8
9
10
11
12
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.